Paclitaxel Treatment and Proprotein Convertase 1/3 (PC1/3) Knockdown in Macrophages is a Promising Antiglioma Strategy as Revealed by Proteomics and Cytotoxicity Studies [Liečba paklitaxelom a vylučovanie PC1/3 v makrofágoch je sľubnou stratégiou antigliómu, ako sa ukázalo v štúdiách proteomiky a cytotoxicity].
About the publication
Record:
DUHAMEL, Marie - ROSE, Mélanie - RODET, Franck - MURGOCI, Adriana - Natalia - ZOGRAFIDOU, Lea - RÉGNIER-VIGOUROUX, Anne - VANDEN ABEELE, Fabien - KOBEISSY, Firas - NATAF, Serge - PAYS, Laurent - WISZTORSKI, Maxence - ČÍŽKOVÁ, Dáša - FOURNIER, Isabelle - SALZET, Michel. Paclitaxel Treatment and Proprotein Convertase 1/3 (PC1/3) Knockdown in Macrophages is a Promising Antiglioma Strategy as Revealed by Proteomics and Cytotoxicity Studies [Liečba paklitaxelom a vylučovanie PC1/3 v makrofágoch je sľubnou stratégiou antigliómu, ako sa ukázalo v štúdiách proteomiky a cytotoxicity]. In: Molecular and Cellular Proteomics. 2018. ISSN 1535-9476, Vol. 17, č. 6(2018), s. 1126-1143.
(2018: 4.828 - IF, 181 - H-index, 5.914 - IF 5y, 2.807 - SJR, Q1 - SJR Best Q, Q1 - JCR Best Q)
(2018: 4.828 - IF, 181 - H-index, 5.914 - IF 5y, 2.807 - SJR, Q1 - SJR Best Q, Q1 - JCR Best Q)
Year:
2018
Category:
ADC - Scientific papers in foreign journals
Authors:
DUHAMEL Marie
35 %
ROSE Mélanie
5 %
RODET Franck
5 %
MURGOCI Adriana - Natalia
5 %
ZOGRAFIDOU Lea
5 %
RÉGNIER-VIGOUROUX Anne
5 %
VANDEN ABEELE Fabien
5 %
KOBEISSY Firas
5 %
NATAF Serge
5 %
PAYS Laurent
5 %
WISZTORSKI Maxence
5 %
5 %
FOURNIER Isabelle
5 %
SALZET Michel
5 %
UVMP share:
5 %
Edition:
Molecular and Cellular Proteomics
Vol. 17, č. 6(2018), s. 1126-1143
Country of issue:
Slovakia
ISSN:
1535-9476
Research area:
130 - Sciences about living nature
Scientometrics:
2018: 4.828 - IF, 181 - H-index, 5.914 - IF 5y, 2.807 - SJR, Q1 - SJR Best Q, Q1 - JCR Best Q
Language:
english
Citations:
2024-2024: [1] GAWEL, Agata M. - BETKOWSKA, Anna - GAJDA, Ewa - GODLEWSKA, Marlena - GAWEL, Damian. Current Non-Metal Nanoparticle-Based Therapeutic Approaches for Glioblastoma Treatment. In Biomedicines, 2024-08-01, 12, 8, pp. Dostupné na: https://doi.org/10.3390/biomedicines12081822.
2024-2024: [1] MA, Tianfei - SU, Gang - WU, Qionghui - SHEN, Minghui - FENG, Xinli - ZHANG, Zhenchang. Tumor-derived extracellular vesicles: how they mediate glioma immunosuppression. In Molecular Biology Reports, 2024-12-01, 51, 1, pp. ISSN 03014851. Dostupné na: https://doi.org/10.1007/s11033-023-09196-5.
2024-2024: [1] RAFFO-ROMERO, Antonella - ZIANE-CHAOUCHE, Lydia - SALOMÉ-DESNOULEZ, Sophie - HAJJAJI, Nawale - FOURNIER, Isabelle - SALZET, Michel - DUHAMEL, Marie. A co-culture system of macrophages with breast cancer tumoroids to study cell interactions and therapeutic responses. In Cell Reports Methods, 2024-06-17, 4, 6, pp. Dostupné na: https://doi.org/10.1016/j.crmeth.2024.100792.
2024-2024: [1] SU, Pengfei - LI, Ou - KE, Kun - JIANG, Zhichen - WU, Jianzhang - WANG, Yuanyu - MOU, Yiping - JIN, Weiwei. Targeting tumor‑associated macrophages: Critical players in tumor progression and therapeutic strategies (Review). In International Journal of Oncology, 2024-01-01, 64, 6, pp. ISSN 10196439. Dostupné na: https://doi.org/10.3892/ijo.2024.5648.
2023-2023: [1] WENG, D.F. - HE, L. - CHEN, X.N. - LIN, H.F. - JI, D.H. - LU, S.T. - AO, L. - WANG, S.L. Integrated analysis of transcription factor-mRNA-miRNA regulatory network related to immune characteristics in medullary thyroid carcinoma. In FRONTIERS IN IMMUNOLOGY. ISSN 1664-3224, 2023, vol. 13, art. no. 1055412.
2022-2022: [1] LU, Jianglong - XU, Fanjie - RAO, Changjun - SHEN, Chaodong - JIN, Jinghao - ZHU, Zhangzhang - WANG, Chengde - LI, Qun. Mechanism of action of paclitaxel for treating glioblastoma based on single-cell RNA sequencing data and network pharmacology. In FRONTIERS IN PHARMACOLOGY, 2022, vol. 13, no., pp. Dostupné na: https://doi.org/10.3389/fphar.2022.1076958.
2019-2019: [1] LARIONOVA, Irina - CHERDYNTSEVA, Nadezhda - LIU, Tengfei - PATYSHEVA, Marina - RAKINA, Militsa - KZHYSHKOWSKA, Julia. Interaction of tumor-associated macrophages and cancer chemotherapy. In ONCOIMMUNOLOGY. ISSN 2162-402X, 2019, vol. 8, no. 7, pp.
2019-2019: [1] LI, Guoxiong - HUANG, Min - CAI, Yingqian - YANG, Yuantao - SUN, Xinlin - KE, Yiquan. Circ-U2AF1 promotes human glioma via derepressing neuro-oncological ventral antigen 2 by sponging hsa-miR-7-5p. In JOURNAL OF CELLULAR PHYSIOLOGY. ISSN 0021-9541, 2019, vol. 234, no. 6, pp. 9144-9155. [WoS]